From evidence to action

At ICARS, our mission is to partner with low- and middle-income countries (LMICs) in their efforts to reduce drug-resistant infections.

We do this by co-developing tailored solutions with LMIC governments and researchers, who then implement them on the ground using ICARS funding and expertise, building on AMR National Action Plans.

Follow us and view our latest news

4. June 2021

DDL June 15th: let’s partner to advance the implementation of your antimicrobial resistance NAP

Ministries from Low- and Middle-Income Countries can submit Expressions of Interest to partner with ICARS before June 15th.
10. May 2021

We are hiring!

Applications are now closed.

Our projects inform policy and practice around the world

At ICARS, we simultaneously use top-down and bottom-up approaches, engaging with government ministries while involving scientists and practitioners throughout the process.

See all projects

Vietnam: partnership between ICARS and the Ministry of Agriculture and Rural Development (MARD)

Read about our projects

Georgia: partnership between ICARS and two Georgian ministries

Discover our projects

Join our mission

To achieve sustainable change in LMICs, we invite countries and foundations to join us as Founding or Supporting Members,
in a truly international effort to mitigate antimicrobial resistance.

Please do not hesitate to contact our team for further information.

Find out more      Contact us

ICARS on Twitter

Get the latest updates about ICARS on Twitter

Please do not hesitate to contact our Team for further information.

Follow us on Twitter

Last day to apply for the #ECCMID Outreach Grant which covers conference registration fees for participants from #LMICs.

Have you registered yet?

#opportunity #research #grant @ESCMID

The new @WHO Report on the Global #AntimicrobialResistance and Use Surveillance System (GLASS) has been released today. See below the statement of support from our Scientific Director @RskSkov.

👉Read the full report here:

#StopSuperbugs #GlobalHealth

Load more of our Tweets...